Anxiety and Depression Symptoms Vary Among IBD Patients

(MedPage Today) -- Psychological health status varies along with IBD
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news

Related Links:

Conclusions Mindfulness-based group cognitive behavior and education support group therapy are effective in reducing pain and distress. However, women in the M-gCBT program showed greater improvement in certain secondary outcomes, indicating that M-gCBT may offer some advantages in reducing distress associated with provoked localized vulvodynia.
Source: Journal of Lower Genital Tract Disease - Category: OBGYN Tags: Benign Vulvovaginal Disorders Source Type: research
Publication date: May 2019Source: Epilepsy &Behavior, Volume 94Author(s): Victor Navarrete-Modesto, Sandra Orozco-Suárez, Mario Alonso-Vanegas, Iris A. Feria-Romero, Luisa RochaAbstractThe Repressor Element-1 Silencing Transcription factor or Neuron-Restrictive Silencer Factor (REST/NRSF) is a zinc finger repressor transcription factor of the Kruppel family. Several studies in experimental models have shown that overexpression of REST/NRSF occurs after the induction of seizures. In the present study, the expression of REST/NRSF (messenger ribonucleic acid (mRNA) and protein) was evaluated in the hippocampus of 2...
Source: Epilepsy and Behavior - Category: Neurology Source Type: research
Authors: Leman J, Walton S, Layton AM, Ward KA, McBride S, Cliff S, Downs A, Landeira M, Bewley A Abstract Psoriasis can adversely affect quality of life (QoL) and emotional well-being. In this UK prospective observational study we evaluated the 'real-world' impact of adalimumab on QoL and the physical/psychological effects of moderate-to-severe psoriasis. 143 biologic-naïve patients with moderate-to-severe psoriasis, receiving adalimumab in clinical practice, were included. Patients completed a series of questionnaires at baseline (adalimumab initiation), 4 and 16-weeks and 6-months post-adalimumab initiation...
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
It’s no secret that spending time surrounded by nature is not only good for our physical health, but our mental health as well. Being in nature can benefit those with depression and has been shown to reduce anxiety and improve mood. Creativity and problem-solving are enhanced in nature and a walk in the park can improve cardiovascular function. There are so many varied benefits to embracing our natural environment. In fact, forest bathing, which involves slowing down and mindfully immersing ourselves in nature, is becoming popular around the country. Clearly many of us are aware of the benefits of being close to the...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Children and Teens Green and Environment Child Development Nature Source Type: blogs
Conclusions: The present results showed that the training of spiritual intelligence could develop the nurses' competence in spiritual care. The development of spiritual care provided by nurses can result in various outcomes such as increased satisfaction with care in patients, reduced anxiety and symptoms of depression during hospitalization, reduced length of hospitalization and, in general, improved quality of life. PMID: 30894893 [PubMed - in process]
Source: Journal of Medicine and Life - Category: General Medicine Tags: J Med Life Source Type: research
The more mental health problems people had early on, the greater their memory problems in later life. → Support PsyBlog for just $4 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
Source: PsyBlog | Psychology Blog - Category: Psychiatry & Psychology Authors: Tags: Depression subscribers-only Source Type: blogs
Conditions:   Depression;   Anxiety;   PTSD;   Conduct Disorder;   Oppositional Defiant Disorder Interventions:   Behavioral: t-CETA;   Behavioral: Médecins du Monde treatment as usual Sponsors:   Queen Mary University of London;   Médecins du Monde;   American University of Beirut Medical Center;   Johns Hopkins University;   Medical School Hamburg Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSION: The present findings documented distinct differences in somatosensory function in patients with primary BMS compared to controls, indicating a complex pathophysiology and interaction between impairments in nociceptive processing and psychologic functioning. PMID: 30893407 [PubMed - as supplied by publisher]
Source: Journal of Orofacial Pain - Category: ENT & OMF Tags: J Oral Facial Pain Headache Source Type: research
Authors: Marković V, Purić D, Vukosavljević-Gvozden T, Begović A Abstract The Metacognitions Questionnaire (MCQ-30) is a brief multidimensional measure used for assessment of metacognitive beliefs in psychopathology. The aim of this study was to assess the psychometric properties of MCQ-30 in Serbian non-clinical (n=246) and clinical (n=171; anxiety and depressive disorders) samples. The reliability of the questionnaire and its subscales was satisfactory. An exploratory factor analysis yielded a five factor solution in both groups, while a confirmatory factor analysis showed a somewhat weaker fit of the model. ...
Source: Clinical Psychology and Psychotherapy - Category: Psychiatry Tags: Clin Psychol Psychother Source Type: research
AbstractAlzheimer ’s disease (AD) is the most common form of dementia characterized by the prevalent memory impairment. Mild cognitive impairment (MCI) may represent the early stage of AD, in particular when MCI patients show biomarkers consistent with AD pathology (MCI due to AD). Neuropsychiatric symptoms (NPS) f requently affect both MCI and AD patients. Cerebrospinal-fluid (CSF) tau and β-amyloid42 (A β42) levels are actually considered the most sensitive and specific biomarkers for AD neurodegeneration. In the present retrospective observational study, we evaluated CSF biomarkers and neuropsychological...
Source: Neurological Sciences - Category: Neurology Source Type: research
More News: Anxiety | Depression | Psychiatry | Psychology